Form 4: Surgery Partners CEO Sells Shares for Tax Obligations

Surgery Partners CEO Jason Eric Evans sold 20,400 shares of common stock to cover tax liabilities from restricted stock vesting.

Summary

• Jason Eric Evans, Chief Executive Officer of Surgery Partners, Inc. (SGRY), sold 20,400 shares of the company's common stock.
• The transaction occurred on March 16, 2026, at a weighted average price of $12.47 per share.
• The sale was executed to satisfy tax withholding obligations in connection with the vesting of restricted stock on March 4, 2026.
• Following this transaction, Mr. Evans beneficially owns 920,386 shares of Surgery Partners common stock.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event, typical for executive compensation structures involving restricted stock vesting and subsequent tax obligations. It does not reflect a discretionary sale based on market sentiment.

Positives

• The sale was explicitly for tax withholding obligations, indicating a prior restricted stock award vested, which can be a positive for executive compensation and retention.

Negatives

• A sale of 20,400 shares by the CEO, even for tax purposes, represents a reduction in direct ownership, which some investors might view with slight caution, though it is a common practice.

Future Outlook

NA

Industry Context

StockSavvy.ai notes that insider sales for tax obligations are a routine part of executive compensation plans, particularly with restricted stock units (RSUs) or similar equity awards. This type of transaction is common across various industries when equity awards vest and does not typically signal a change in management's outlook or company fundamentals.

Comparison to Industry Standards

• This transaction aligns with standard practices for executive equity compensation across publicly traded companies, where a portion of vested shares is often sold to cover statutory tax withholding requirements.

Stakeholder Impact

• Shareholders: The sale represents a minor dilution, but the underlying vesting event is a positive for executive retention. The transaction's stated purpose (tax obligations) suggests it is not a discretionary sale based on negative sentiment, thus limiting significant negative impact on shareholder perception.
• Employees: The vesting of restricted stock and subsequent tax-related sale is a standard component of executive compensation, which can be viewed positively for executive motivation and alignment with company performance.

Key Dates

Recommendation

This Form 4 filing details a routine, non-discretionary sale of shares by the CEO to cover tax obligations arising from restricted stock vesting. Such transactions are common and do not typically signal a change in management's outlook or a fundamental shift in the company's prospects. Therefore, it provides no new information to warrant a change from a 'hold' recommendation.

Keywords

Surgery Partners, SGRY, Jason Eric Evans, CEO, Insider Trading, Stock Sale, Restricted Stock, Tax Withholding, Form 4